US equities
|
TSLA
$352.47
▼-2.75%
MU
$894.87
▼-3.91%
NVDA
$215.74
▼-0.69%
AAPL
$342.53
▲+0.15%
SPCX
$145.79
▼-1.90%
META
$712.88
▼-3.24%
SNDK
$1,323.25
▼-5.13%
MSFT
$526.11
▼-2.47%
TSLA
$352.47
▼-2.75%
MU
$894.87
▼-3.91%
NVDA
$215.74
▼-0.69%
AAPL
$342.53
▲+0.15%
SPCX
$145.79
▼-1.90%
META
$712.88
▼-3.24%
SNDK
$1,323.25
▼-5.13%
MSFT
$526.11
▼-2.47%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by ReShape Lifesciences
Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND
August 13, 2025
From
ReShape Lifesciences
Via
Business Wire
Tickers
RSLS
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics
August 07, 2025
From
ReShape Lifesciences
Via
Business Wire
Tickers
RSLS
